Month: June 2024

FirstService Residential Further Enhances Market Leadership Position in California

FirstService Residential Further Enhances Market Leadership Position in California

Acquires CitiScape Property Management Group TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that FirstService Residential, the North American residential property management leader, has acquired San Francisco-based CitiScape Property Management Group, LLC (“CitiScape”). CitiScape’s existing executive team will continue to lead day-to-day operations. Terms of the transaction were not disclosed. Founded in 1999, CitiScape is a leading full-service community association management firm in the San Francisco metropolitan market, providing a range of property management and project management services to high-rise condominium and homeowner association clients. The acquisition solidifies FirstService Residential’s market leadership in the Bay Area of Northern California. “The...

Continue reading

Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes

Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes

– Ziftomenib induces insulin production, improves insulin sensitivity and reduces insulin resistance in preclinical model of type 2 diabetes – – Kura advancing multiple, next-generation menin inhibitor drug candidates targeting diabetes and other metabolic diseases – SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported preclinical data supporting the potential therapeutic utility of menin inhibitors in the treatment of diabetes. The new findings were presented this weekend at the American Diabetes Association’s 84th Scientific Sessions in Orlando. Copies of the presentation are available in the Posters and Presentations section on Kura’s website. “Despite the...

Continue reading

Red Pine Announces Completion of Verification of Gold Assay Results Database to Support Updated Mineral Resource Estimate

Red Pine Announces Completion of Verification of Gold Assay Results Database to Support Updated Mineral Resource Estimate

TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) reports that it has completed the verification of all gold assay certificates received by the Company from 2014 to the present for the Wawa Gold Project. Paul Martin, Interim CEO and Chair of the Board of Red Pine commented: “We are pleased to have completed the reconciliation between our drill hole database and the one built independently by WSP Global Inc. (“WSP”). This marks a critical step towards completing an updated mineral resource estimate.” As reported in its press release of May 6, 2024, the Company engaged WSP to lead an independent data verification of all gold assay certificates from 2014 to the present. Copies of the gold assay certificates were sent directly to WSP by the two assay labs used...

Continue reading

Great Elm Capital Corp. (“GECC”) Raises $12 Million of Equity at Net Asset Value

Great Elm Capital Corp. (“GECC”) Raises $12 Million of Equity at Net Asset Value

PALM BEACH GARDENS, Fla., June 24, 2024 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ: GECC), a business development company, today announced it issued approximately 1.0 million shares of the Company’s common stock at a current net asset value of $12.03 per share, for an aggregate gross purchase price of $12 million, to Prosper Peak Holdings, LLC (“PPH”). Great Elm Group, Inc. (“GEG”), the parent of the Company’s investment manager, made a $3 million investment in PPH, further aligning it with shareholders. “We have raised $38 million of non-dilutive equity year-to-date, bolstering our efforts to expand the platform,” said Matt Kaplan, GECC’s Chief Executive Officer. “Our gross net asset value by dollars has grown by nearly 80% since management and the board were refreshed in March 2022, benefiting...

Continue reading

Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease

Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease

WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced new preclinical data in a Pompe disease model demonstrating the potential of the FORCE™ platform to deliver enzyme replacement therapy to cardiac and skeletal muscle and the central nervous system (CNS). The data were presented at the New Directions in Biology and Disease of Skeletal Muscle Conference, being held June 23-26 in Fort Lauderdale, FL. “These preclinical data show for the first time the ability of FORCE to deliver enzymes to skeletal and cardiac muscle as well as the CNS, expanding the modularity of our platform beyond oligonucleotides. The data support the...

Continue reading

NowVertical Group to Host Live Corporate Webinar on July 12th at 10:00 am ET

NowVertical Group to Host Live Corporate Webinar on July 12th at 10:00 am ET

TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”) announces that the Company’s CEO, Sandeep Mendiratta, will be presenting an overview of the Company, including an in-depth discussion into current operations and milestones while also providing an outlook for 2024 at a corporate webinar on July 12. We invite all investors and other interested parties to register for the webinar at the link below. NowVertical Group to Host Live Corporate Webinar on July 12th at 10:00 am ET NowVertical Group’s CEO, Sandeep Mendiratta, will be hosting a webinar to provide updates on our integration strategy, share progress so far, and outline future milestones. The session will conclude with a live Q&A. You may submit your question(s) beforehand in the registration form linked...

Continue reading

MoneyHero Group Reports First Quarter 2024 Results

MoneyHero Group Reports First Quarter 2024 Results

First quarter revenue of US$22.2 million, up 24% Year-Over-Year SINGAPORE, June 24, 2024 (GLOBE NEWSWIRE) — MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced financial results for the quarter ended March 31, 2024. Management Commentary: Rohith Murthy, Chief Executive Officer, stated, “I am pleased to report another strong quarter, with revenue increasing by 24% year-over-year to $22.2 million. This significant growth underscores the effectiveness of our strategic initiatives and the robust performance across our core markets. Despite Q1 historically being a lower quarter due to the Chinese New Year holidays and the shorter month of February, which typically results in a drop from Q4...

Continue reading

Entrada Therapeutics Announces $100 Million Registered Direct Offering

Entrada Therapeutics Announces $100 Million Registered Direct Offering

– The offering was led by a U.S.-based healthcare focused investor, two global mutual funds and Janus Henderson Investors, a global asset management firm – BOSTON, June 24, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. The Company today announced that it has entered into a securities purchase agreement with a group of investors for the purchase of 3,367,003 shares of common stock and pre-funded warrants to purchase up to 3,367,003 shares of common stock in a registered direct offering for aggregate gross proceeds of approximately $100 million. The offering was led by a U.S.-based healthcare focused investor, two global...

Continue reading

Elanders announces date for the report on the second quarter 2024 and conference call

Elanders announces date for the report on the second quarter 2024 and conference call

Elanders will issue its report on the second quarter 2024 on Friday 12 July, 2024, at 07:30 CET, followed by a conference call at 09:00 CET, hosted by Magnus Nilsson, President and CEO, and Åsa Vilsson, CFO. We invite fund managers, analysts and the media to participate in the conference call. To join, register your details using the registration link below. Once registered, you will receive a separate email containing dial in number(s) and PINs. Register for the conference call here. Agenda08:50 Conference number is opened 09:00 Presentation of the quarterly report 09:20 Q&A10:00 End of the conference During the conference call a presentation will be held. To access the presentation, please use this link: https://www.elanders.com/presentations For further questions, please contactMagnus Nilsson, President and CEO, telephone: +46...

Continue reading

Canoo Received Discounted Manufacturing Assets at Oklahoma Facilities

Canoo Received Discounted Manufacturing Assets at Oklahoma Facilities

Bolsters Automation and Scale for Made-in-America EVs JUSTIN, Texas, June 24, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today announced that it has received the first of two tranches of new or like-new advanced manufacturing assets, formerly owned by Arrival Automotive UK Limited, at its Foreign Trade Zone (FTZ) designated facility in Oklahoma City, OK. The received assets will bolster in-house processes and enable higher cabin line production volumes in 2025. Canoo received 44 containers with 226 lots of advanced manufacturing assets including state-of-the-art robots along with a suite of comprehensive production infrastructure. These assets will streamline Canoo’s production processes, leading to reduced lead times, enhanced production scalability, lower capital expenditures, and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.